Valeant Product Producer Progenics Announce European Approval For RELISTOR To Treat All Opioid Induced Constipation

By: via Benzinga
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX:VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.